Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
Clondalkin Group makes two promotions
Clondalkin Group makes two promotions
David Lennon and Paddy Mullaney become joint Chief Executives
John Trizzino returns to Novavax
John Trizzino returns to Novavax
As Senior Vice President of Commercial Operations
Eisai names new CEO and COO
Eisai names new CEO and COO
To replace current President and CEO who is retiring in June
Judith Charles joins Owen Mumford
Judith Charles joins Owen Mumford
Takes the role of Sales and Marketing Director
Canbex Therapeutics appoints Chief Medical Officer
Canbex Therapeutics appoints Chief Medical Officer
Dr Alberto Lledó spent 16 years at Eli Lilly
Jungheinrich appoints UK Business Development Manager
Jungheinrich appoints UK Business Development Manager
Mike Young joins Systems & Projects division
Novasep appoints CEO Michel Spagnol as Chairman of the Supervisory Board
Novasep appoints CEO Michel Spagnol as Chairman of the Supervisory Board
He replaces Roger-Marc Nicoud
Prothena makes a promotion
Prothena makes a promotion
Tara Nickerson becomes Chief Business Officer at Dublin-based company
Codexis appoints Patrick Yang to Board of Directors
Codexis appoints Patrick Yang to Board of Directors
He has broad experience in pharmaceutical manufacturing and process development
Hua Mu to head product development service and partnership business at WuXi PharmaTech
Hua Mu to head product development service and partnership business at WuXi PharmaTech
Joins the company from Hutchison MediPharma
New President and Vice Chancellor for Queen\'s University Belfast
New President and Vice Chancellor for Queen\'s University Belfast
Cancer researcher Professor Patrick Johnston takes the role
Biotec Services International appoints new Chief Executive
Biotec Services International appoints new Chief Executive
UK-headquartered Biotec Services International promotes Fiona Withey to role
Bacteriologist Pascale Cossart wins 2013 Women in Science Award
Bacteriologist Pascale Cossart wins 2013 Women in Science Award
For her contributions to the study of how bacteria infect human and other cells
CluePoints adds three people to its global team
CluePoints adds three people to its global team
To develop business on the East and West coasts of North America
Catalent makes two appointments to strengthen its biologics business
Catalent makes two appointments to strengthen its biologics business
Will drive growth in the biologics sector and in SMARTag antibody drug conjugates technology
Dr Allison Jeynes-Ellis becomes Chief Executive at Avillion
Dr Allison Jeynes-Ellis becomes Chief Executive at Avillion
Founding member of management team and formerly Chief Medical Officer at the company
Previous
1
…
129
130
131
132
(current)
133
134
135
…
214
Next
Trending Articles
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
MHRA scientific leader recognised in 2026 King's Birthday Honours
Dr Nicola Rose receives OBE for services to science and public health
Hansa Biopharma appoints Fredrik Röök as VP Business Development
Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) today announced that Fredrik Röök has been appointed as VP Business Development effective 17th August. Mr Röök will report to CEO Renée Aguiar-Lucander
Siddharth Mittal appointed as Managing Director & CEO of Syngene International
Syngene International, a global contract research, development, and manufacturing organisation (CRDMO), today announced that Siddharth Mittal has assumed the role of Managing Director and Chief Executive Officer of the Company, effective 1 July 2026
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all